Posted by Michael Wonder on 07 Jul 2020
Abandoning list prices in Medicaid drug reimbursement did not affect spending
7 July 2020 - State fee-for-service Medicaid programs have traditionally based payments to pharmacies for drugs on a percentage of the drugs’ list price.
Because list prices have increased more quickly than the prices actually paid by pharmacies, estimating appropriate reimbursements has become challenging.
In recent years most states have switched to models where payments were based instead on results from a survey of pharmacy invoices.
